MedTrace Logo

Transcranial Direct Current Stimulation for Freezing of Gait

NCT02266004 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2020-06-30

Study results available
· View outcomes & findings →

Summary

This study will evaluate the effects of transcranial direct current stimulation (tDCS) in combination with locomotor training in patients with Parkinson's disease (PD) and freezing of gait (FOG).

Conditions

Interventions

DEVICE

Transcranial Direct Current Stimulation (tDCS)

Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.

OTHER

locomotor training

An individualized dual-task walking program for approximately 30 minutes.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Corneliu Luca, MD, PhD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-12
Primary Completion
2018-06-27
Completion
2018-06-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02266004 on ClinicalTrials.gov